跳至主要内容
临床试验/CTRI/2025/07/091805
CTRI/2025/07/091805暂停Unknown

An Open Label, Single Arm Clinical Study to Evaluate the safety and efficacy of Sakriyam Pain Oil for the patients with Muscular pain.

Jeena Sikho Lifecare Limited1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2025年8月8日最近更新:

试验速览

阶段
Unknown
状态
暂停
发起方
入组人数
36
试验地点
1
主要终点
2. Change in WOMAC score

研究概览

简要总结

An Open Label, Single Arm Clinical Study to Evaluate the safety and efficacy of Sakriyam Pain Oil for the patients with Muscular pain.

Patients will be assigned to investigational product for 30 days, following up on 1st, 15th  and 30th

Primary  outcomes: 1.  Musculoskeletal Health Questionnaire, 2.   WOMAC, 3.SGA

Secondary outcomes:  1.VAS, 2. EQ-5D-5L

Subjects from 18 to 65 years of age.

Test Product: Sakriyam Pain Oil

Dose**:** Apply oil two times a day

Route of Administration: Topical

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Subjects having Muscular pain.
  • Subjects from 18 to 65 years of age.
  • If female with childbearing potential, must be willing to practice an acceptable form of birth control for the duration of the study.
  • Subjects that are able to give written informed consent in a manner approved by the institutional ethics committee and comply with the requirements of the study.
  • Subjects willing to avoid participation in any other interventional clinical trial for the duration of the study.

排除标准

  • Subjects that are pregnant, breast feeding, or planning to get pregnant during the study.
  • Subjects that have participated in any other interventional clinical trial in the previous 30 days.
  • Subjects with known sensitivity to any of the constituents of the investigational product.

结局指标

主要结局

2. Change in WOMAC score

时间窗: Time Frame Day1, Day15 and Day30

1. Change in SGA score

时间窗: Time Frame Day1, Day15 and Day30

3. Change in Musculoskeletal Health score

时间窗: Time Frame Day1, Day15 and Day30

次要结局

  • 1. Change in VAS score(2. Change in EQ-5D-5L Score)

研究者

发起方
Jeena Sikho Lifecare Limited
申办方类型
Pharmaceutical industry-Indian
责任方
Principal Investigator
主要研究者

Dr Manoj Sharma

GS Ayurveda Medical College & Hospital Pilkhuwa Hapur

研究点 (1)

Loading locations...

相似试验